Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,354,476
+$143,997 QoQ
Shares Held
166,659
+12.9% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 94.48634637193311.ToString("F0")%
None 5.5136536280668915.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. PTCT ranks #43 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in PTCT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,354,476 | 166,659 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,210,479 | 147,584 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $652,362 | 10,630 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $519,168 | 10,630 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $925,585 | 18,163 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,938,040 | 42,934 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,562,125 | 69,060 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,411,293 | 78,852 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,142,507 | 73,651 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,025,604 | 73,498 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $14,247,782 | 635,778 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,316,233 | 401,186 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,926,304 | 81,055 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,982,702 | 51,944 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $876,893 | 17,468 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $712,626 | 17,789 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $672,250 | 18,018 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $559,060 | 11,807 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,685,159 | 27,612 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,937,319 | 41,440 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,942,412 | 57,990 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,312,805 | 51,845 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||